BioLife Solutions Inc
BLFS20.975USD
+0.170+0.82%
Horário de mercado （ET）Cotações atrasadas em 15 min
997.33MValor de mercado
PerdaP/L TTM
Mais detalhes de BioLife Solutions Inc Empresa
BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
Informações da empresa
Código da empresaBLFS
Nome da EmpresaBioLife Solutions Inc
Data de listagemNov 22, 1989
CEOMr. Roderick De Greef
Número de funcionários159
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 22
EndereçoSuite 310
CidadeBOTHELL
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal98021
Telefone14254011400
Sitehttps://www.biolifesolutions.com/
Código da empresaBLFS
Data de listagemNov 22, 1989
CEOMr. Roderick De Greef
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
255.09K
-0.21%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
151.87K
-0.26%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
118.82K
-48.71%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
101.78K
-0.85%
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
98.49K
-0.31%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
51.56K
-0.38%
Mr. Joydeep Goswami
Mr. Joydeep Goswami
Independent Director
Independent Director
41.11K
-14.33%
Sean Werner
Sean Werner
Chief Technology Officer
Chief Technology Officer
26.50K
-4.04%
Ms. Amy Duross
Ms. Amy Duross
Lead Independent Director
Lead Independent Director
23.81K
-22.41%
Ms. Catherine (Cathy) Coste
Ms. Catherine (Cathy) Coste
Independent Director
Independent Director
5.70K
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
255.09K
-0.21%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
151.87K
-0.26%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
118.82K
-48.71%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
101.78K
-0.85%
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
98.49K
-0.31%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
51.56K
-0.38%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Product Revenue-Cell processing
21.57M
90.11%
Rental Revenue- Evo and thaw
1.58M
6.61%
Product Revenue- Evo and thaw
725.00K
3.03%
Service Revenue-Evo and thaw
60.00K
0.25%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Product Revenue-Cell processing
21.57M
90.11%
Rental Revenue- Evo and thaw
1.58M
6.61%
Product Revenue- Evo and thaw
725.00K
3.03%
Service Revenue-Evo and thaw
60.00K
0.25%
Distribuição de ações
Atualizado em: qua, 30 de jul
Atualizado em: qua, 30 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Casdin Capital, LLC
16.11%
BlackRock Institutional Trust Company, N.A.
10.60%
Invesco Advisers, Inc.
6.96%
The Vanguard Group, Inc.
5.84%
Fred Alger Management, LLC
3.21%
Other
57.28%
Investidores
Investidores
Proporção
Casdin Capital, LLC
16.11%
BlackRock Institutional Trust Company, N.A.
10.60%
Invesco Advisers, Inc.
6.96%
The Vanguard Group, Inc.
5.84%
Fred Alger Management, LLC
3.21%
Other
57.28%
Tipos de investidores
Investidores
Proporção
Investment Advisor
41.95%
Investment Advisor/Hedge Fund
33.97%
Hedge Fund
18.28%
Research Firm
2.34%
Individual Investor
2.24%
Pension Fund
1.49%
Bank and Trust
0.53%
Sovereign Wealth Fund
0.08%
Insurance Company
0.03%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
411
48.30M
100.98%
-4.50M
2025Q1
430
51.12M
107.57%
-1.38M
2024Q4
407
48.89M
104.05%
-2.49M
2024Q3
404
46.98M
101.82%
-6.27M
2024Q2
385
48.82M
105.97%
-2.22M
2024Q1
377
46.95M
103.67%
-5.60M
2023Q4
397
47.58M
108.04%
-4.07M
2023Q3
399
45.29M
104.13%
-2.05M
2023Q2
401
44.87M
103.50%
-2.76M
2023Q1
408
43.41M
100.74%
-4.46M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Casdin Capital, LLC
7.71M
16.2%
-1.03M
-11.77%
Jun 10, 2025
BlackRock Institutional Trust Company, N.A.
5.07M
10.66%
-141.26K
-2.71%
Mar 31, 2025
Invesco Advisers, Inc.
3.33M
7%
+274.55K
+8.99%
Mar 31, 2025
The Vanguard Group, Inc.
2.80M
5.88%
-32.12K
-1.14%
Mar 31, 2025
Fred Alger Management, LLC
1.53M
3.22%
-61.10K
-3.83%
Mar 31, 2025
State Street Global Advisors (US)
1.43M
3.01%
-35.28K
-2.40%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
1.35M
2.83%
+1.35M
--
Mar 31, 2025
Rockefeller Capital Management
964.26K
2.03%
+142.49K
+17.34%
Mar 31, 2025
Palisade Capital Management, LLC
947.09K
1.99%
+113.94K
+13.68%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
920.27K
1.93%
+33.27K
+3.75%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
Invesco S&P SmallCap Health Care ETF
0.57%
Invesco S&P SmallCap 600 Pure Growth ETF
0.52%
First Trust Multi-Manager Small Cap Opportunities ETF
0.38%
iShares Micro-Cap ETF
0.18%
First Trust Active Factor Small Cap ETF
0.18%
SPDR S&P 600 Small Cap Growth ETF
0.12%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.12%
iShares S&P Small-Cap 600 Growth ETF
0.11%
First Trust Small Cap Growth AlphaDEX Fund
0.1%
iShares Core S&P Small-Cap ETF
0.06%
Ver Mais
Invesco S&P SmallCap Health Care ETF
Proporção0.57%
Invesco S&P SmallCap 600 Pure Growth ETF
Proporção0.52%
First Trust Multi-Manager Small Cap Opportunities ETF
Proporção0.38%
iShares Micro-Cap ETF
Proporção0.18%
First Trust Active Factor Small Cap ETF
Proporção0.18%
SPDR S&P 600 Small Cap Growth ETF
Proporção0.12%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proporção0.12%
iShares S&P Small-Cap 600 Growth ETF
Proporção0.11%
First Trust Small Cap Growth AlphaDEX Fund
Proporção0.1%
iShares Core S&P Small-Cap ETF
Proporção0.06%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
